Breaking News

Arranta Bio Establishes Commercial-Ready Manufacturing Facility

Enables the CDMO to supply vital products to patients in need.

By: Contract Pharma

Contract Pharma Staff

Arranta Bio, a microbiome contract development and manufacturing organization (CDMO), has announced the mechanical completion of GMP suites at its Watertown, MA commercial-ready facility.   Arranta is investing more than $100 million in 2020 to establish a multi-product, commercial-ready manufacturing facility that will supply live biotherapeutic products (LBPs) to microbiome innovator companies. The Watertown facility has been designed to the highest specifications for advanced biologics produc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters